A randomized controlled study to compare 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) for the prevention of post-operative recurrence of bladder cancer

A randomized controlled study to compare 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) for the prevention of post-operative recurrence of bladder cancer

To evaluate the effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU), a derivative of 5-fluorouracil (5-FU), in preventing postoperative recurrence of bladder cancer, a randomized controlled study with 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) as the reference standard was performed. HCFU was given...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 31(1985), 7 vom: 15. Juli, Seite 1233-41
1. Verfasser: Misaki, T (VerfasserIn)
Weitere Verfasser: Hisazumi, H, Sakai, A, Nakamura, T, Kanda, S, Mikawa, I, Miyagi, T, Katsumi, T, Orito, M, Kawaguchi, K
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1985
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial Journal Article Randomized Controlled Trial Antineoplastic Agents Tegafur 1548R74NSZ carmofur HA82M3RAB2 Fluorouracil U3P01618RT